Peter Sinnaeve

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Jan Steffel, Peter Verhamme, Tatjana Potpara et al. · European Heart Journal · 2018 · 2.1K citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

Stefan Janssens, Christophe Dubois, Jan Bogaert et al. · The Lancet · 2006 · 1.3K citations

Medicine, Cardiology, Internal Medicine +12

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

Renato D. Lópes, Gretchen Heizer, Ronald Aronson et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Hein Heidbüchel, Peter Verhamme, Marco Alings et al. · EP Europace · 2015 · 1.1K citations

Medicine, Cardiology, Pharmacotherapy +14